{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:25:08Z","timestamp":1792801508538,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s40120-025-00716-y","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T10:05:32Z","timestamp":1740218732000},"page":"643-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"14","author":[{"given":"Yang","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaQin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaBin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuXuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-3928","authenticated-orcid":false,"given":"JiFeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"716_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20:385\u201397.","journal-title":"Lancet Neurol"},{"key":"716_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet (London, England). 2015;386:896\u2013912.","journal-title":"Lancet (London, England)"},{"key":"716_CR3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT. Parkinson\u2019s disease and parkinsonism. Am J Med. 2019;132:802\u20137.","journal-title":"Am J Med"},{"key":"716_CR4","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR. Parkinson\u2019s disease. Lancet (London, England). 2004;363:1783\u201393.","journal-title":"Lancet (London, England)"},{"key":"716_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/WNL.56.6.730","volume":"56","author":"D Aarsland","year":"2001","unstructured":"Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-S\u00f8rensen P. Risk of dementia in Parkinson\u2019s disease: a community-based, prospective study. Neurology. 2001;56:730\u20136.","journal-title":"Neurology"},{"key":"716_CR6","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mds.23661","volume":"26","author":"C Vossius","year":"2011","unstructured":"Vossius C, Larsen JP, Janvin C, Aarsland D. The economic impact of cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2011;26:1541\u20134.","journal-title":"Mov Disord"},{"key":"716_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27:349\u201356.","journal-title":"Mov Disord"},{"key":"716_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19:1020\u20138.","journal-title":"Mov Disord"},{"key":"716_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","volume":"17","author":"J Marinus","year":"2018","unstructured":"Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ. Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet Neurol. 2018;17:559\u201368.","journal-title":"Lancet Neurol"},{"key":"716_CR10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/mds.27002","volume":"32","author":"J Hoogland","year":"2017","unstructured":"Hoogland J, Boel JA, de Bie RMA, et al. Mild cognitive impairment as a risk factor for Parkinson\u2019s disease dementia. Mov Disord. 2017;32:1056\u201365.","journal-title":"Mov Disord"},{"key":"716_CR11","doi-asserted-by":"publisher","first-page":"e1650","DOI":"10.1212\/WNL.0000000000010347","volume":"95","author":"SJ Chung","year":"2020","unstructured":"Chung SJ, Lee HS, Kim HR, et al. Factor analysis-derived cognitive profile predicting early dementia conversion in PD. Neurology. 2020;95:e1650\u20139.","journal-title":"Neurology"},{"key":"716_CR12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","volume":"60","author":"NI Bohnen","year":"2003","unstructured":"Bohnen NI, Kaufer DI, Ivanco LS, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol. 2003;60:1745\u20138.","journal-title":"Arch Neurol"},{"key":"716_CR13","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.aaz5891","volume":"367","author":"A Westbrook","year":"2020","unstructured":"Westbrook A, van den Bosch R, M\u00e4\u00e4tt\u00e4 JI, et al. Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work. Science (New York, NY). 2020;367:1362\u20136.","journal-title":"Science (New York, NY)"},{"key":"716_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi JC, Hirth F. Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson\u2019s disease. Front Neurosci. 2018;12:80.","journal-title":"Front Neurosci"},{"key":"716_CR15","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8:1150\u20137.","journal-title":"Lancet Neurol"},{"key":"716_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.002","volume":"73","author":"SG Ryman","year":"2020","unstructured":"Ryman SG, Poston KL. MRI biomarkers of motor and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2020;73:85\u201393.","journal-title":"Parkinsonism Relat Disord"},{"key":"716_CR17","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1523\/JNEUROSCI.23-15-06351.2003","volume":"23","author":"SJ Lewis","year":"2003","unstructured":"Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in early Parkinson\u2019s disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci. 2003;23:6351\u20136.","journal-title":"J Neurosci"},{"key":"716_CR18","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/archneurol.2011.725","volume":"68","author":"D Weintraub","year":"2011","unstructured":"Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol. 2011;68:1562\u20138.","journal-title":"Arch Neurol"},{"key":"716_CR19","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1212\/WNL.0b013e318259e1c5","volume":"78","author":"GA Carlesimo","year":"2012","unstructured":"Carlesimo GA, Piras F, Assogna F, Pontieri FE, Caltagirone C, Spalletta G. Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study. Neurology. 2012;78:1939\u201345.","journal-title":"Neurology"},{"key":"716_CR20","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mds.27682","volume":"34","author":"Y Li","year":"2019","unstructured":"Li Y, Wang C, Wang J, et al. Mild cognitive impairment in de novo Parkinson\u2019s disease: a neuromelanin MRI study in locus coeruleus. Mov Disord. 2019;34:884\u201392.","journal-title":"Mov Disord"},{"key":"716_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","volume":"75","author":"JR Winer","year":"2018","unstructured":"Winer JR, Maass A, Pressman P, et al. Associations between tau, \u03b2-amyloid, and cognition in Parkinson disease. JAMA Neurol. 2018;75:227\u201335.","journal-title":"JAMA Neurol"},{"key":"716_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116189","volume":"206","author":"ET Rolls","year":"2020","unstructured":"Rolls ET, Huang CC, Lin CP, Feng J, Joliot M. Automated anatomical labelling atlas 3. Neuroimage. 2020;206: 116189.","journal-title":"Neuroimage"},{"key":"716_CR23","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Can Res. 2017;77:e104\u20137.","journal-title":"Can Res"},{"key":"716_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med. 2018;16:34.","journal-title":"BMC Med"},{"key":"716_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, et al. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science (New York, NY). 2012;338:949\u201353.","journal-title":"Science (New York, NY)"},{"key":"716_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41531-023-00531-y","volume":"9","author":"K Kaleck\u00fd","year":"2023","unstructured":"Kaleck\u00fd K, Bottiglieri T. Targeted metabolomic analysis in Parkinson\u2019s disease brain frontal cortex and putamen with relation to cognitive impairment. NPJ Parkinson\u2019s Dis. 2023;9:84.","journal-title":"NPJ Parkinson's Dis"},{"key":"716_CR27","doi-asserted-by":"crossref","unstructured":"Suo X, Lei D, Li N, et al. Brain functional network abnormalities in parkinson's disease with mild cognitive impairment. Cerebral Cortex (New York, NY 1991). 2022;32:4857\u201368.","DOI":"10.1093\/cercor\/bhab520"},{"key":"716_CR28","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1111\/ene.15489","volume":"29","author":"CE Cicero","year":"2022","unstructured":"Cicero CE, Donzuso G, Luca A, et al. Morphometric magnetic resonance imaging cortico-subcortical features in Parkinson\u2019s disease with mild cognitive impairment. Eur J Neurol. 2022;29:3197\u2013204.","journal-title":"Eur J Neurol"},{"key":"716_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/B978-0-444-64196-0.00013-3","volume":"166","author":"BA Vogt","year":"2019","unstructured":"Vogt BA. Cingulate cortex in Parkinson\u2019s disease. Handb Clin Neurol. 2019;166:253\u201366.","journal-title":"Handb Clin Neurol"},{"key":"716_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41573-023-00823-1","volume":"23","author":"B Dejanovic","year":"2024","unstructured":"Dejanovic B, Sheng M, Hanson JE. Targeting synapse function and loss for treatment of neurodegenerative diseases. Nat Rev Drug Discov. 2024;23:23\u201342.","journal-title":"Nat Rev Drug Discov"},{"key":"716_CR31","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10072-020-04626-9","volume":"42","author":"S Chaudhary","year":"2021","unstructured":"Chaudhary S, Kumaran SS, Goyal V, et al. Frontal lobe metabolic alterations characterizing Parkinson\u2019s disease cognitive impairment. Neurol Sci. 2021;42:1053\u201364.","journal-title":"Neurol Sci"},{"key":"716_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/jnnp-2022-330154","volume":"94","author":"A Singh","year":"2023","unstructured":"Singh A, Cole RC, Espinoza AI, Wessel JR, Cavanagh JF, Narayanan NS. Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2023;94:945\u201353.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"716_CR33","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1212\/WNL.0000000000200344","volume":"99","author":"PS Myers","year":"2022","unstructured":"Myers PS, O\u2019Donnell JL, Jackson JJ, et al. Proteinopathy and longitudinal cognitive decline in Parkinson disease. Neurology. 2022;99:e66\u201376.","journal-title":"Neurology"},{"key":"716_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.parkreldis.2022.01.002","volume":"95","author":"H Chen","year":"2022","unstructured":"Chen H, Wan H, Zhang M, Wardlaw JM, Feng T, Wang Y. Perivascular space in Parkinson\u2019s disease: association with CSF amyloid\/tau and cognitive decline. Parkinsonism Relat Disord. 2022;95:70\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"716_CR35","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1016\/j.neuron.2023.10.030","volume":"111","author":"F Bassil","year":"2023","unstructured":"Bassil F, Brown HJ, Pattabhiraman S, et al. Amyloid-beta (A\u03b2) Plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology. Neuron. 2023;111:3699.","journal-title":"Neuron"},{"key":"716_CR36","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1093\/brain\/awad265","volume":"146","author":"N Vijiaratnam","year":"2023","unstructured":"Vijiaratnam N, Foltynie T. How should we be using biomarkers in trials of disease modification in Parkinson\u2019s disease? Brain. 2023;146:4845\u201369.","journal-title":"Brain"},{"key":"716_CR37","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3233\/JAD-200344","volume":"76","author":"GM Sancesario","year":"2020","unstructured":"Sancesario GM, Di Lazzaro G, Alwardat M, et al. Amyloid-\u03b242\/neurogranin ratio as a potential index for cognitive impairment in Parkinson\u2019s disease. J Alzheimer\u2019s Dis. 2020;76:1171\u20138.","journal-title":"J Alzheimer's Dis"},{"key":"716_CR38","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fneur.2019.01066","volume":"10","author":"AC Salas-Leal","year":"2019","unstructured":"Salas-Leal AC, Sandoval-Carrillo A, Romero-Guti\u00e9rrez E, et al. rs3764435 associated with Parkinson\u2019s disease in Mexican mestizos: case-control study reveals protective effects against disease development and cognitive impairment. Front Neurol. 2019;10:1066.","journal-title":"Front Neurol"},{"key":"716_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ana.26410","volume":"92","author":"J Shen","year":"2022","unstructured":"Shen J, Amari N, Zack R, et al. Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson\u2019s disease. Ann Neurol. 2022;92:255\u201369.","journal-title":"Ann Neurol"},{"key":"716_CR40","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mds.26172","volume":"30","author":"LM Bekris","year":"2015","unstructured":"Bekris LM, Tsuang DW, Peskind ER, et al. Cerebrospinal fluid A\u03b242 levels and APP processing pathway genes in Parkinson\u2019s disease. Mov Disord. 2015;30:936\u201344.","journal-title":"Mov Disord"},{"key":"716_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12436","volume":"9","author":"C Padulo","year":"2023","unstructured":"Padulo C, Sestieri C, Punzi M, et al. Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment. Alzheimer\u2019s Dement (New York, N Y). 2023;9: e12436.","journal-title":"Alzheimer's Dement (New York, N Y)"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00716-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00716-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00716-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T03:31:10Z","timestamp":1741836670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00716-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00716-y","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was based on an open-source, public database; therefore, the requirement for written informed consent from participants was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Yang Luo, YaQin Xiang, JiaBin Liu, YuXuan Hu, and JiFeng Guo declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}